Otamixaban in acute coronary syndromes

被引：7

作者：

Eikelboom, John W. ^{[1
,2
]}

Weitz, Jeffrey I. ^{[2
,3
,4
]}

机构：

[1] Hamilton Gen Hosp, Thrombosis Serv, Hamilton, ON L8L 2X2, Canada

[2] McMaster Univ, Dept Med, Hamilton, ON, Canada

[3] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada

[4] Henderson Res Ctr, Hamilton, ON, Canada

来源：

LANCET | 2009年 / 374卷 / 9692期

关键词：

FACTOR XA INHIBITOR; FACTOR-IXA ACTIVITY; DOUBLE-BLIND; TRIAL; ASPIRIN;

D O I：

10.1016/S0140-6736(09)61529-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：762 / 764

页数：3

共 11 条

[1] Apixaban, an Oral, Direct, Selective Factor Xa Inhibitor, in Combination With Antiplatelet Therapy After Acute Coronary Syndrome Results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) Trial [J].

Alexander, John H. ;

Becker, Richard C. ;

Bhatt, Deepak L. ;

Cools, Frank ;

Crea, Filippo ;

Dellborg, Mikael ;

Fox, Keith A. A. ;

Goodman, Shaun G. ;

Harrington, Robert A. ;

Huber, Kurt ;

Husted, Steen ;

Lewis, Basil S. ;

Lopez-Sendon, Jose ;

Mohan, Puneet ;

Montalescot, Gilles ;

Ruda, Mikhail ;

Ruzyllo, Witold ;

Verheugt, Freek ;

Wallentin, Lars ;

Darius, Harald ;

Simoons, Maarten ;

Boersma, Eric ;

DeLemos, James ;

Spencer, Fred .

CIRCULATION, 2009, 119 (22) :2877-U39

[2] Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease [J].

Chan, Mark Y. ;

Cohen, Mauricio G. ;

Dyke, Christopher K. ;

Myles, Shelley K. ;

Aberle, Laura G. ;

Lin, Min ;

Walder, James ;

Steinhubl, Steven R. ;

Gilchrist, Ian C. ;

Kleiman, Neal S. ;

Vorchheimer, David A. ;

Chronos, Nicholas ;

Melloni, Chiara ;

Alexander, John H. ;

Harrington, Robert A. ;

Tonkens, Ross M. ;

Becker, Richard C. ;

Rusconi, Christopher P. .

CIRCULATION, 2008, 117 (22) :2865-2874

[3] Randomized, double-blind, dose-ranging study of otamixaban, a novel, parenteral, short-acting direct factor Xa inhibitor, in percutaneous coronary intervention - The SEPIA-PCI trial [J].

Cohen, Marc ;

Bhatt, Deepak L. ;

Alexander, John H. ;

Montalescot, Gilles ;

Bode, Christoph ;

Henry, Timothy ;

Tamby, Jean-Francois ;

Saaiman, Jan ;

Simek, Stanislas ;

De Swart, Johannes .

CIRCULATION, 2007, 115 (20) :2642-2651

[4] First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology - A phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity [J].

Dyke, Christopher K. ;

Steinhubl, Steven R. ;

Kleiman, Neal S. ;

Cannon, Richard O. ;

Aberle, Laura G. ;

Lin, Min ;

Myles, Shelley K. ;

Melloni, Chiara ;

Harrington, Robert A. ;

Alexander, John H. ;

Becker, Richard C. ;

Rusconi, Christopher P. .

CIRCULATION, 2006, 114 (23) :2490-2497

[5] The discovery of the factor Xa inhibitor otamixaban: From lead identification to clinical development [J].

Guertin, Kevin R. ;

Choi, Yong-Mi .

CURRENT MEDICINAL CHEMISTRY, 2007, 14 (23) :2471-2481

[6] Warfarin, aspirin, or both after myocardial infarction. [J].

Hurlen, M ;

Abdelnoor, M ;

Smith, P ;

Erikssen, J ;

Arnesen, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :969-974

[7] Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial [J].

Mega, J. L. ;

Braunwald, E. ;

Mohanavelu, S. ;

Burton, P. ;

Poulter, R. ;

Misselwitz, F. ;

Hricak, V. ;

Barnathan, E. S. ;

Bordes, P. ;

Witkowski, A. ;

Markov, V. ;

Oppenheimer, L. ;

Gibson, C. M. .

LANCET, 2009, 374 (9683) :29-38

[8] RNA aptamers as reversible antagonists of coagulation factor IXa [J].

Rusconi, CP ;

Scardino, E ;

Layzer, J ;

Pitoc, GA ;

Ortel, TL ;

Monroe, D ;

Sullenger, BA .

NATURE, 2002, 419 (6902) :90-94

[9] Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial [J].

Sabatine, Marc S. ;

Antman, Elliott M. ;

Widimsky, Petr ;

Ebrahim, Iftikhar O. ;

Kiss, Robert G. ;

Saaiman, Andre ;

Polasek, Rostislav ;

Contant, Charles F. ;

McCabe, Carolyn H. ;

Braunwald, Eugene .

LANCET, 2009, 374 (9692) :787-795

[10] Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial [J].

van Es, RF ;

Jonker, JJC ;

Verheugt, FWA ;

Deckers, JW ;

Grobbee, DE .

LANCET, 2002, 360 (9327) :109-113

← 1 2 →